The Latest Breaking News from FDA

Democratic and leftist groups prepare for potential challenges to abortion access under a Trump administration, with blue state governors stockpiling Mifep...

Are the risks and costs worth it to keep crow's feet at bay? Experts weigh in.

Attorneys general across the U.S. have a new fight on their hands: protecting Americans from unproven and expensive stem cell treatments that salespeople claim can cure almost anything

The recent Supreme Court ruling on technical grounds has upheld the availability of the abortion pill mifepristone in the United States. While this decision is a temporary win for abortion rights advocates, it is not the final word on the issue, and there are indications that opponents of abortion will…

‘Civil War’ star credits intermittent fasting for his recent weight loss

The justices unanimously rejected the mifepristone case on technical grounds. Their ruling is not the victory it may seem

The Nasdaq and S&P 500 hit record highs on tame inflation and as Apple, Broadcom and Oracle soared on news. But the stock market gains were narrow.

The low-calorie sweetener is often marketed as a healthy glucose alternative.

The justices agreed that the plaintiffs didn't have standing to sue on the issue.